About Crescent R&D Private Limited
Data last updated:
Crescent R&D Private Limited is a private limited company based in Sriperumbudur, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2014PTC096380. Its GSTIN is 33AAMCA7215L1ZJ (Tamil Nadu).
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹7.5 Cr. It is led by directors including Laith Khalid Aldoori and Mohammed Khalid Aldoori.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 27 Sipcot Industrial Park, Sriperumbudur, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.67 Cr, a decline of 57% compared to the previous year. For the same year it recorded a net profit of ₹1.82 Cr (net margin 12.4%) and EBITDA of ₹3.38 Cr (EBITDA margin 23.1%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 17% over five years.
The company has about 98 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹40.75 Cr on record. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.5 Cr; the latest was in December 2019. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Sridhara Laboratories Private Limited with revenue of ₹14.8 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website archimedis.net.
Company details
Contact details
Crescent R&D Private Limited's registered office is in Sriperumbudur, Tamil Nadu. Its website is archimedis.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC – 27 Sipcot Industrial Park, Irungattukottal, Sriperumbudur, Tamil Nadu, India – 602117
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Crescent R&D Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Crescent R&D is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Crescent R&D Private Limited, buy the company report.
Financials of Crescent R&D Private Limited
FY 2024 filings availableCrescent R&D Private Limited reported revenue of ₹14.67 Cr (down 57% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 57% fall in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.1% | ||||
| Net Profit Margin | 12.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crescent R&D Private Limited, buy the company report.
Board of directors of Crescent R&D Private Limited
Crescent R&D has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Laith Khalid Aldoori Also directs: S. Zhaveri Pharmakem Private Limited | Director | 10 May 2023 | 3 Years 5 Months | Current |
| Mohammed Khalid Aldoori Also directs: S. Zhaveri Pharmakem Private Limited | Director | 10 May 2023 | 3 Years 5 Months | Current |
| Samie Mohammed Aldoori Also directs: S. Zhaveri Pharmakem Private Limited | Director | 10 May 2023 | 3 Years 5 Months | Current |
| Ravin Pawar | Director | 22 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Crescent R&D Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sridhara Laboratories Private Limited | ₹14.8 Cr (FY 2025) | 37.0% | Hyderabad, Telangana, India | |||
| Crescent R&D Private Limitedthis company | ₹14.67 Cr (FY 2024) | ₹1.82 Cr | 12.4% | -57.0% | 98 | Sriperumbudur, Tamil Nadu, India |
| Decro Pharma Private Limited | ₹14.66 Cr (FY 2025) | 96.0% | Indrad, Gujarat, India | |||
| Life Medicare and Biotech Private Limited | ₹14.62 Cr (FY 2025) | 328658.0% | New Delhi, Delhi, India |
To see the full peer comparison of Crescent R&D Private Limited, buy the company report.
Auditor
Crescent R&D Private Limited is audited by ESSVEEYAR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ESSVEEYAR & CO | FY 2023 | 000808S |
Shareholding
The shareholding of Crescent R&D Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Crescent R&D Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Aug 2020 | 100363586 | Sidbi | ₹14.5 Lakh | Satisfied | |
| 18 Dec 2019 | 100312487 | Sidbi | ₹3.94 Cr | Satisfied | |
| 16 Jul 2016 | 100050412 | Axis Bank Limited | ₹14.57 Cr | Satisfied | |
| 30 Aug 2014 | 10528542 | Bank of India | ₹17.09 Cr | Satisfied | |
| 28 Aug 2014 | 10555180 | Bank of India | ₹5 Cr | Satisfied |
To see the full charge records of Crescent R&D Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Crescent R&D Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.5 Cr; the latest was in December 2019.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2019 | Funding round | ₹1.5 Cr | Investors: 2 individuals |
| Aug 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Crescent R&D Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crescent R&D Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Crescent R&D Private Limited has a workforce of 98 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Crescent R&D has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAMCA7215L1ZJ | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Crescent R&D Private Limited, buy the company report.
Recent activity
Crescent R&D Private Limited has 14 board changes on record since 2017: 5 appointments and 9 cessations. The latest: Ravin Pawar ceased to be Additional Director on 29 Sep 2024.
17 earlier events are in the company report.
Frequently asked questions
Crescent R&D is an active private limited company based in Sriperumbudur, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 July 2014 (12+ years old) and is registered under CIN U74900TN2014PTC096380.
Crescent R&D has 4 current directors:
- Laith Khalid Aldoori - Director
- Mohammed Khalid Aldoori - Director
- Samie Mohammed Aldoori - Director
- Ravin Pawar - Director
The latest financial statements of Crescent R&D on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Crescent R&D is 33AAMCA7215L1ZJ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Crescent R&D is U74900TN2014PTC096380. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crescent R&D was incorporated on 02 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
Crescent R&D has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.5 Cr; the latest was in December 2019.
The peers of Crescent R&D by revenue are Sridhara Laboratories Private Limited, Decro Pharma Private Limited, Life Medicare and Biotech Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravin Pawar ceased to be Additional Director on 29 Sep 2024. Ravin Pawar was appointed as Director on 22 Aug 2024. Laith Khalid Aldoori ceased to be Additional Director on 19 Sep 2023. Crescent R&D has 14 board changes on record in total.
Crescent R&D can be reached through the website archimedis.net. Its registered office is in Sriperumbudur, Tamil Nadu, India.
The registered office of Crescent R&D is at C – 27 Sipcot Industrial Park, Irungattukottal, Sriperumbudur, Tamil Nadu, India – 602117.